Concepedia

Author

André Vertruyen

AZ Sint-Blasius

Also Known As

Andre F. Vertruyen, Andre Vertruyen, André Vertruyen

14

Publications

1.1K

Citations

13

H-Index

14

Concepts

All Affiliations

AZ Sint-BlasiusGZA Ziekenhuizen Campus Sint-AugustinusNovartis (Italy)Hospital de BasurtoInternational Centre for Diarrhoeal Disease Research
AV

About

André Vertruyen is an author at AZ Sint-Blasius specializing in vaccine safety, influenza vaccines, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

205

2

Epidemiology

2

2

117

3

Immunology

2

2

62

4

Preventive Medicine

2

2

117

5

Vaccine Development

1

1

67

André Vertruyen

×

13

Publications

1K

Citations

13

H-Index

YearCitations

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

Shai Ashkenazi, André Vertruyen, Javier Ar stegui,

The Pediatric Infectious Disease Journal

2006

313

Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care

Timo Vesikari, Douglas Fleming, Javier Arı́stegui,

PEDIATRICS

2006

179

Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial

Bárður Sigurgeirsson, Andrzej Boznański, Gail Todd,

PEDIATRICS

2015

145

Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

Carine Claeys, Khalequ Zaman, Ghassan Dbaibo,

The Lancet Child & Adolescent Health

2018

76

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

Lucy Chai See Lum, Charissa Borja-Tabora, Robert F. Breiman,

Vaccine

2009

67

Twice‐daily versus Once‐daily Applications of Pimecrolimus Cream 1% for the Prevention of Disease Relapse in Pediatric Patients with Atopic Dermatitis

M. Ruer‐Mulard, Werner Aberer, Anthony Gunstone,

Pediatric Dermatology

2009

46

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis

Steven Black, Giovanni Della Cioppa, Anne Malfroot,

Vaccine

2010

41

Immunogenicity and Safety of a Pediatric Dose of a Virosome-Adjuvanted Hepatitis A Vaccine

Marie Van der Wielen, André Vertruyen, G Froesner,

The Pediatric Infectious Disease Journal

2007

39

Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist™ Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma

Andrea von Berg, Prakash Jeena, Peter A. Soemantri,

Pediatric Pulmonology

2004

36

Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age

Luisanna Zedda, Eduardo Forleo‐Neto, André Vertruyen,

The Pediatric Infectious Disease Journal

2014

34

Page 1